Trends in cancer of the cervix uteri in Sweden following cytological screening
about
HPV and Cervical Cancer: Updates on an Established RelationshipAneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicantsCarcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.Major clinical research advances in gynecologic cancer 2009.Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesionsProspective study of human papillomavirus and risk of cervical adenocarcinomaUneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study.Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.The frequency of Pap smear screening in the United States.Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009Age-period-cohort effect on mortality from cervical cancer.Cervical cancer in the screening era: who fell victim in spite of successful screening programs?Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysisShort-time repeat high-risk HPV testing by self-sampling for screening of cervical cancerCost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance.Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesionsThe significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer.Incidence and survival rate of women with cervical cancer in the Greater Amsterdam areaComparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis.Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria.Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ.Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.Self-sampling of the vaginal fluid at home combined with high-risk HPV testing.Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia.Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population.Nonattendance in a cervical cancer screening program - what happens if women's requirements are met?Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening.Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.Age and Pattern of Pap Smear Abnormalities: Implications for Cervical Cancer Control in a Developing Country.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program.HPV prevalence and HPV-related dysplasia in elderly women.Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Māori women.
P2860
Q22305479-BF961DBE-6774-4187-B826-7063D19DD682Q28078495-E6B4F1E2-2185-42F9-A6B8-170BCE2D5F60Q31009526-3CA9DB0B-055A-4C5C-8F4E-08C72EA17DA9Q33560967-65E78EF9-2D90-498D-AF66-8B50D1563AA5Q33685531-F4AF3138-8E06-4E0C-A7E4-A499BC8B5254Q34091747-9144CB0F-BF3E-403D-B66C-BA1B93F9DCEBQ34141644-B7D96423-F740-4A83-9574-8F920F62774EQ34243766-B1B7E459-C2C9-4C53-B5BB-0013E6B50CD2Q34731765-E36C3600-2FC1-4487-BC87-645639F0F79BQ34972824-2BB16E16-BDE8-444D-A945-DD3CB1735A75Q34987542-1EC91E2D-A900-4745-A552-3356E6466D8FQ35154522-1A511FF2-F176-42FA-8F04-56C6052D6134Q35287686-097FBECA-A192-4AC0-8224-7540A10ADC1CQ35287748-7C7417DB-164D-4B39-B5EF-393B16C90AB1Q35784964-43005F36-8869-4F35-A0C1-2A8190ECEBAAQ35836050-23BCD4C9-3BA8-437F-B6F4-4316A003A657Q36608745-D7EE9C80-A836-460D-9F0B-074F41C27A38Q36612129-BF7E2D86-D0EB-4833-BF68-086E9B4325E5Q36641924-7E5A4E8B-935A-48F2-8AAC-E5828A0C6F32Q36643598-5B4AFE74-5946-4D9E-8231-0DC2D28CC13EQ36648058-18EF2B01-17B9-4F5A-8969-6E10091D9E4BQ36671743-123CE886-A5D9-4D69-97BC-BF67BD4CB20BQ36695068-CE2BDBB4-6D47-41DC-A04C-66AFE1CC3006Q36858251-75B9A121-29C7-4EBB-BB32-119695794C65Q36981026-9D9A6889-7775-4418-94B3-44AB77A22C02Q37092723-77E72CA2-FECF-4FE6-9FEA-CB500CD096C9Q37158156-D27957C0-E7A3-4669-9D28-2B192CD6D8B6Q37330757-314D54A6-CD0E-4108-8EEF-F119E4BCB120Q37333259-1931F653-D8CB-449B-9073-DE4BC9F37948Q38655636-580A7B34-772C-4830-9381-F819185F0D63Q38850741-313051B2-9486-4EA4-98A9-62821B1EA0DEQ40112465-B6699F73-C1E2-4D97-AB28-EFFA1B5CB422Q42212838-E4790B8F-A75A-4BDD-A57E-F17ABAF47309Q42721299-E2912EBB-B1FE-4A40-BFA2-F07CA363271BQ44320222-777EB9E9-9435-4070-865B-4CF87E9602D0Q44771964-8D43424C-89D2-4264-BB09-0BFD92C229D9Q44876752-9AF22232-18B0-4FDF-AA4A-42DE738CE03BQ45820502-82BECACA-4B3A-4163-A303-127EBBC5D89EQ47556043-247C4006-66B0-416B-BC70-36392D4D9071Q47847003-DB7597D7-6540-428C-AD44-19DD22483288
P2860
Trends in cancer of the cervix uteri in Sweden following cytological screening
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Trends in cancer of the cervix uteri in Sweden following cytological screening
@ast
Trends in cancer of the cervix uteri in Sweden following cytological screening
@en
type
label
Trends in cancer of the cervix uteri in Sweden following cytological screening
@ast
Trends in cancer of the cervix uteri in Sweden following cytological screening
@en
prefLabel
Trends in cancer of the cervix uteri in Sweden following cytological screening
@ast
Trends in cancer of the cervix uteri in Sweden following cytological screening
@en
P2860
P356
P1476
Trends in cancer of the cervix uteri in Sweden following cytological screening
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690666
P407
P577
1999-09-01T00:00:00Z